Intra-Cellular Therapies Inc. (ITCI)

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 54.70m
  • Volume: 0
  • RiskGrade: 243

Latest ShareCast News

Johnson & Johnson to buy Intra-Cellular Therapies for $14.6bn

By Michele Maatouk

Date: Monday 13 Jan 2025

(Sharecast News) - Johnson & Johnson confirmed on Monday that it has agreed to buy biopharmaceutical firm Intra-Cellular Therapies for around $14.6bn.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ITCI Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 54.70m
RiskGrade 243

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page